APA (7th ed.) Citation

Hu, X., Ji, Y., Zhang, M., Li, Z., Pan, X., Zhang, Z., & Wang, X. Targeting CXCL8 signaling sensitizes HNSCC to anlotinib by reducing tumor-associated macrophage-derived CLU. BMC.

Chicago Style (17th ed.) Citation

Hu, Xin, Yikang Ji, Mi Zhang, Zhihui Li, Xinhua Pan, Zhen Zhang, and Xu Wang. Targeting CXCL8 Signaling Sensitizes HNSCC to Anlotinib by Reducing Tumor-associated Macrophage-derived CLU. BMC.

MLA (9th ed.) Citation

Hu, Xin, et al. Targeting CXCL8 Signaling Sensitizes HNSCC to Anlotinib by Reducing Tumor-associated Macrophage-derived CLU. BMC.